AbbVie Inc (NYSE:ABBV)

Tuesday’s trading has closed, but ABBV is being traded in the after-hours session. After-Hours quote »
Data as of 4:02pm ET
 +0.28 / +0.41%
Today’s Change
Today|||52-Week Range
3 Simple Reasons Doctors May Stick With Gilead Sciences Instead of AbbVie
11:38am /
Biotech Stock Roundup: Geron Soars on $935M J&J Deal, Gilead's Harvoni Approved in th...
Nov 19 /
AbbVie Takes Aim at Gilead Sciences
8:02am /
Celldex Therapeutics Surges on Positive Rindopepimut Data - Analyst Blog
Nov 18 /
Fast Money Halftime Report Final Trade From November 24
Nov 24 / Benzinga
Roche's (RHHBY) Avastin Label Expansion Approved by FDA - Analyst Blog
Nov 18 /
AbbVie's HCV Cocktail Treatment Closer to EU Approval - Analyst Blog
Nov 24 /
Novartis Presents Data on Heart Failure Candidate LCZ696 - Analyst Blog
Nov 18 /
Novo Nordisk's Victoza Recommended for Label Expansion - Analyst Blog
Nov 24 /
Merck Updates on Anti-PD-1 Drug Keytruda Phase II Study - Analyst Blog
Nov 17 /
Sanofi's (SNY) Cerdelga a Step Closer to European Approval - Analyst Blog
Nov 24 /
Why Top Dividend Stock Johnson & Johnson Could Plunge in 2015
Nov 17 /
3 Biotech Stocks That Could Soar Even Higher
Nov 24 /
7 Biggest Health Problems Americans Face
Nov 16 /
Low Interest Rates, Gas Prices to Fuel Stock Market Gains in 2015
Nov 24 /
AbbVie Inc. vs. Pfizer Inc.: Which Is the Better Dividend Stock?
Nov 16 /
Today AbbVie (ABBV) Hits New Lifetime High
Nov 24 /
Where Will Google Stock Be in 10 Years?
Nov 14 /
Notable Analyst Rating Changes 11/7: (CA) (GNC) (SPLK) Upgraded; (OXY) (ABBV) (SLXP) ...
Nov 23 / Investing Channel
Gilead Reports Promising Data on its HCV Drug Harvoni - Analyst Blog
Nov 12 /
George Soros Just Bought These 3 Stocks: Should You?
Nov 23 /
Regeneron/Sanofi Announce Positive Dupilumab Study Data - Analyst Blog
Nov 12 /
Can New Launches Offset Sanofi's Soft Diabetes Business? - Analyst Blog
Nov 21 /
Biotech Stock Roundup: Gilead, AbbVie Score at Liver Meeting, Dendreon Files for Bank...
Nov 12 /
Amgen and AbbVie Strengthen Manufacturing Facilities in Asia - Analyst Blog
Nov 21 /
Bristol-Myers Gives Updates on HCV Candidate Daclatasvir - Analyst Blog
Nov 11 /
Buy Gilead Sciences
Nov 21 /
Stock Market News for November 11, 2014 - Market News
Nov 11 /
J&J Seeks FDA Approval for Schizophrenia Treatment - Analyst Blog
Nov 20 /
Bets gone awry push Paulson fund to loss
Nov 10 /
Shire to Relocate Employees Under One Shire Program - Analyst Blog
Nov 20 /
Bill Ackman wins Allergan insider trading lawsuit
Nov 04 /
Gilead Gains on Harvoni's EU Approval for HCV Treatment - Analyst Blog
Nov 19 /
Aggressive tax avoidance troubles large investors
Nov 02 /
Pharma Industry Outlook: M&A, Licensing Abound - Zacks Analyst Interviews
Nov 19 /
Pfizer chief: tax inversions still have "meaningful value"
Oct 28 /
Pharma Industry Outlook: M&A, Licensing Abound - Industry Outlook
Nov 19 /
The Silver Economy: Silicon Valley joins quest to 'cure' ageing
Oct 26 /

To view my watchlist

Not a member yet?

Sign up now for a free account

Most stock quote data provided by BATS. Market indices are shown in real time, except for the DJIA, which is delayed by two minutes. All times are ET. Disclaimer.

Morningstar: © 2014 Morningstar, Inc. All Rights Reserved.

Factset: FactSet Research Systems Inc. 2014. All rights reserved.

Chicago Mercantile Association: Certain market data is the property of Chicago Mercantile Exchange Inc. and its licensors. All rights reserved.

Dow Jones: The Dow Jones branded indices are proprietary to and are calculated, distributed and marketed by DJI Opco, a subsidiary of S&P Dow Jones Indices LLC and have been licensed for use to S&P Opco, LLC and CNN. Standard & Poor's and S&P are registered trademarks of Standard & Poor’s Financial Services LLC and Dow Jones is a registered trademark of Dow Jones Trademark Holdings LLC. All content of the Dow Jones branded indices © S&P Dow Jones Indices LLC 2014 and/or its affiliates.